Skip to main content
. 2008 Jun 5;1:5. doi: 10.1186/1756-8722-1-5

Table 2.

Summary of diseases developed in BCR-ABL-GFP and BCR-ABL-GFP + N17 H-Ras mice

Mice CML B-lymphoid leukemia/lymphoma ND*
BCR-ABL-GFP 7/7 0/7 -
BCR-ABL-GFP+ N17 H-Ras 2/12 8/12 2/12

* Not determined.